Login
Merck & Company NYSE: MRK
Merck & Co., Inc. provides healthcare solutions worldwide in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances.
| Name | Merck & Company |
| Ticker | MRK |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
|
Price
52W Low/High |
79.38
72.17 / 86.93 |
| Momentum | Neutral |
| Market cap | 201 B |
| 1Y Total Return |
5.61%
Weak |
| 1Y Volatility |
20.26%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Merck & Co., Inc. provides healthcare solutions worldwide in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances.
Details
| Ticker | MRK |
| Name | Merck & Company |
| ISIN | US58933Y1055 |
| CUSIP | 58933Y105 |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
| Country | USA |
| Currency | U.S. Dollar |
Share as of 5/18/21
| Close Price | 79.38 |
| 52W Low/High | 72.17 / 86.93 |
| Market cap | 201 B |
| 1Y Total Return |
5.61%
Weak |
| 1Y Volatility |
20.26%
Low Risk |
| Beta | 0.21 |
| PE (trailing) |
28.76
Average |
| 12M Dividends | 2.52 |
| Last Dividend Date | 3/12/21 |
| Dividend Yield | 3.17% |
Fin. Strength
| Net Profit Margin | 14.6% |
| Cash from Op. / Cur. Liabilities | 0.43 |
| Diluted Earnings / Share | 2.76 |
| ROE | 26.4% |
| ROIC | 13.4% |
| Price / Revenue | - |
| Price / Book | - |
| Price / CF | - |
| Current Ratio | 1.0 |
| Cur.Liabilities / Tot.Liabilities | 0.4 |
| Financial Leverage | 1.16 |
| in Mils USD |
rolling-year up to March
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Revenue |
48,018
|
48,082
|
43,073
|
40,725
|
39,929
|
39,385
|
|
| Gross Profit |
32,175
|
33,710
|
29,696
|
27,678
|
26,422
|
24,448
|
|
| R&D |
13,815
|
10,150
|
8,487
|
11,706
|
10,431
|
6,627
|
|
| EBITDA |
12,128
|
15,823
|
14,787
|
10,460
|
10,120
|
11,927
|
|
| Operating Income |
7,010
|
12,258
|
10,500
|
5,143
|
5,109
|
7,164
|
|
| Net Income exc. Extra |
7,028
|
10,146
|
8,399
|
1,580
|
4,345
|
4,615
|
|
| per Share | |||||||
| Diluted avg Shares |
-
|
-
|
-
|
-
|
-
|
-
|
|
| EPS exc. Extra |
2.76
|
3.95
|
3.17
|
0.58
|
1.56
|
1.62
|
|
| Dividend |
2.52
|
2.32
|
2.06
|
1.90
|
1.86
|
1.82
|
|
| Div. Yield (an.) |
3.27%
|
3.02%
|
2.48%
|
3.49%
|
2.93%
|
3.44%
|
|
| Balance Sheet | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Total Assets |
90,847
|
84,913
|
82,354
|
86,041
|
96,561
|
98,755
|
|
| Cash, Eq & Invt ShortTerm |
6,981
|
7,432
|
8,798
|
7,346
|
15,249
|
12,943
|
|
| Total Current Assets |
26,909
|
26,174
|
25,351
|
24,085
|
31,530
|
28,772
|
|
| Total Non-Current Assets |
63,938
|
58,739
|
57,003
|
61,956
|
65,031
|
69,983
|
|
| Intangibles |
34,613
|
35,863
|
29,169
|
31,804
|
35,221
|
39,148
|
|
| Total Liabilities |
63,808
|
58,613
|
54,684
|
52,140
|
56,473
|
54,854
|
|
| Total Current Liabilities |
26,361
|
23,483
|
18,543
|
16,960
|
19,823
|
17,568
|
|
| Long Term Debt |
37,447
|
35,130
|
36,141
|
35,180
|
36,650
|
37,286
|
|
| Shareholder equity |
26,945
|
26,205
|
27,539
|
33,668
|
39,837
|
43,806
|
|
| Cash Flow | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Cash from Operations |
11,337
|
12,811
|
11,103
|
7,320
|
8,489
|
12,427
|
|
| Depreciation |
3,734
|
3,575
|
4,280
|
4,620
|
5,103
|
6,299
|
|
| Cash from Investing |
-8,553
|
-4,625
|
4,879
|
-711
|
-1,758
|
3,588
|
|
| Capex |
4,832
|
3,864
|
2,760
|
1,999
|
1,674
|
1,359
|
|
| Cash from Financing |
-3,440
|
-8,737
|
-12,052
|
-14,189
|
-4,717
|
-13,408
|
|
| Stock Issued |
72
|
-4,757
|
-9,081
|
-3,145
|
-2,490
|
-3,639
|
|
| Debt (LT) Issued |
3,014
|
2,057
|
2,664
|
-5,617
|
3,028
|
-4,575
|
|
| Free Cash Flow |
9,080
|
14,923
|
7,856
|
864
|
9,733
|
8,010
|
|
| Ratios | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Net Profit Margin |
14.6%
|
21.1%
|
19.5%
|
3.9%
|
10.9%
|
11.7%
|
|
| NCFO / Op.Income |
161.7%
|
104.5%
|
105.7%
|
142.3%
|
166.2%
|
173.5%
|
|
| Current Ratio |
1.0
|
1.1
|
1.4
|
1.4
|
1.6
|
1.6
|
|
| Financial Leverage D/E |
1.16
|
1.07
|
0.94
|
0.70
|
0.71
|
0.59
|
|
| Return on Capital Avg |
13.4%
|
17.9%
|
11.2%
|
1.4%
|
6.5%
|
7.0%
|
|
| Return on Shareholder Equity |
26.4%
|
37.8%
|
27.4%
|
4.3%
|
10.4%
|
10.1%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available